Skip to main content
Premium Trial:

Request an Annual Quote

ABRF's iPRG Extends Submission Deadline for Study


This story originally ran on Jan. 12.

The Proteome Informatics Research Group of the Association of Biomolecular Resource Facilities said this week it is pushing back the deadline to submit results for this year's study to Jan. 18.

The study on LC-MS/MS data analysis focuses on evaluating participants' abilities to identify phosphopeptides and localize phosphorylation sites. Specifically, laboratories are asked to identify the phosphopeptides present in the sample with a false discovery rate of 1 percent or less; assess the certainty or ambiguity in localizing phosphorylation sites to particular amino acid residues; and complete a survey and attach a one to two page description of methods that were used.

The study survey can be completed here. Results should be submitted in the required Excel template to [email protected], naming the Excel file "iPRG2010sumbission####.xls," using the identifier given to each participant instead of ####.

Results from the study will be presented at ABRF's annual meeting in March.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.